On September 2, 2020 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported that the company’s management will participate in the following investor conferences during the month of September 2020 (Press release, Affimed, SEP 2, 2020, View Source [SID1234564315]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 Wells Fargo Virtual Healthcare Conference (September 9-10, 2020)
Date: Wednesday, September 9, 2020
Presentation Time: Fireside chat with Dr. Jim Birchenough at 8:00 a.m. Eastern Time

Citi’s 15th Annual BioPharma Virtual Conference (September 8-11, 2020)
Date: Wednesday, September 10, 2020
Affimed will host meetings with investors at the conference

Cantor Fitzgerald Virtual Global Healthcare Conference 2020 (September 15-17, 2020)
Date: Thursday, September 17, 2020
Presentation Time: 12:40 p.m. Eastern Time

Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit (September 21-23, 2020)
Date: Monday, September 21, 2020
Presentation Time: 3:20 p.m. Eastern Time
Location: Virtual

Webcasts of each presentation may be accessed on Affimed’s website at View Source For more information on the conferences or to schedule a one-on-one meeting with Affimed management, please contact your conference representative or Alex Fudukidis via email at [email protected] or phone at (917) 436-8102.